No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable ...

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential. Total return includes interest, ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...

Two new COVID-19 variants are spreading through the U.S., and medical providers in Connecticut are expecting an uptick in cases in the coming weeks.